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The influence of asthma candidate genes on the development from wheeze to asthma in
young children still needs to be defined.
Objective
To link genetic variants in asthma candidate genes to progression of wheeze to persistent
wheeze into childhood asthma.
Materials and Methods
In a prospective study, children with recurrent wheeze from the ADEM (Asthma DEtection
and Monitoring) study were followed until the age of six. At that age a classification (tran-
sient wheeze or asthma) was based on symptoms, lung function and medication use. In
198 children the relationship between this classification and 30 polymorphisms in 16 asth-
ma candidate genes was assessed by logistic regression. In case of an association based
on a p<0.10, replication analysis was performed in an independent birth cohort study
(KOALA study, n = 248 included for the present analysis).
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Results
In the ADEM study, the minor alleles of ADAM33 rs511898 and rs528557 and the
ORMDL3/GSDMB rs7216389 polymorphisms were negatively associated, whereas the
minor alleles of IL4 rs2243250 and rs2070874 polymorphisms were positively associated
with childhood asthma. When replicated in the KOALA study, ADAM33 rs528557 showed a
negative association of the CG/GG-genotype with progression of recurrent wheeze into
childhood asthma (0.50 (0.26-0.97) p = 0.04) and no association with preschool wheeze.
Conclusion
Polymorphisms in ADAM33, ORMDL3/GSDMB and IL4 were associated with childhood
asthma in a group of children with recurrent wheeze. The replication of the negative associ-
ation of the CG/GG-genotype of rs528557 ADAM33 with childhood asthma in an indepen-
dent birth cohort study confirms that a compromised ADAM33 gene may be implicated in
the progression of wheeze into childhood asthma.
Introduction
Asthma is a common disease in childhood. Twin studies have demonstrated a large contribu-
tion of genetic factors to the development of asthma.[1,2] While the cumulative effect of genet-
ic factors may be large, the individual contribution of each factor may be limited. Recently
much progress has been made in the field of asthma genetics with the introduction of the ge-
nome wide association studies (GWAS). However, these GWAS use general definitions of
(doctors diagnosed) asthma, and the specific effect of many candidate genes in relation to the
development from wheeze to asthma in young children still needs to be defined.
Asthma is characterized by chronic airway inflammation and airway (hyper-) responsive-
ness.[3,4] Although asthma starts with wheeze, not all wheezing children will develop asthma.
[4,5] It is assumed that at a young age a dysfunction of the maturating immune system at a
young age caused by genetic predisposition in combination with environmental triggers, such
as environmental tobacco smoke and bacterial infections, can lead to asthma. [6–8] Several
asthma candidate genes can be functionally implicated in asthma onset and development.
Amongst these are pro-inflammatory genes (IL4, IL5, IL8, IL13, IL33, TNFα), anti-
inflammatory genes (IL10, CC16), genes involved in airway remodelling (ADAM33, PLAUR
and possibly ORMDL3/GSDMB), genes involved in the epithelial barrier function (PCDH1 and
possibly ORMDL3/GSDMB), genes involved in leukocyte (ICAM1) or eosinophil activity
(ORMDL3/GSDMB) and genes involved in immune modulation (IL4R, LTC4, IL1RL1).
The linkage of genetic variants in asthma candidate genes to progression from early wheeze
to persistent wheeze into childhood asthma is expected to result into an increased insight into
the pathophysiology of asthma. We therefore aimed to link genetic variants in various asthma
candidate genes to progression of early wheeze to persistent wheeze and childhood asthma.
Next, we aimed to replicate our findings in an independent birth cohort study.
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Methods
The ADEM study
Study population of the ADEM study. The Asthma DEtection and Monitoring (ADEM)
study is a long-term case-control study executed in the Netherlands and is registered at clinical-
trial.gov (NCT 00422747). The aim of this study is to develop a non-invasive instrument for an
early asthma diagnosis in children and to study aetiological factors in relation to the early de-
velopment of asthma.[9] A total of 202 children with recurrent wheeze (2 episodes during
life according to the International Study of Asthma and Allergies in Childhood (ISAAC) ques-
tionnaire)[10] and 50 healthy controls (random selection of children without wheezing epi-
sodes during life) at two to four years of age were included. Exclusion criteria were mental
retardation, cardiac anomalies, congenital malformations, other diseases of the lungs/airways,
Crohn’s disease or rheumatic arthritis, and the inability to perform lung function measure-
ments or exhaled breath collection. For the current analysis, only the children with recurrent
wheeze were included.
Asthma classification in the ADEM study. At the age of six years a classification (tran-
sient wheezer or true asthmatic) was assessed by an experienced paediatrician in the field of re-
spiratory medicine. This classification was based on symptoms, lung function (reversibility to a
β2-agonist and bronchial hyper-responsiveness) and medication use. In addition to this clinical
classification, the classification was assessed by a computer-calculated algorithm as described
previously.[11] Bronchial hyper-responsiveness (a 20% fall in forced expiratory volume in one
second (FEV1) induced by a provocative concentration of histamine<2 mg/ml) and reversibil-
ity measurements (bronchodilator reversibility9%) were performed according to the Europe-
an Respiratory Society guideline.[12] Mismatching cases between the clinical and the computer
classification were re-evaluated by the same paediatrician, who was blinded to his
previous assessment.
DNA isolation and genotyping in the ADEM study. Saliva was collected by Oragene
DNA self-collection kits (Oragene, Ottowa, Canada). If children were unable to produce suffi-
cient saliva, buccal cells were obtained. DNA was isolated according to the manufacturer’s pro-
tocol. Participants were genotyped for 30 single nucleotide polymorphisms (SNPs) in 16 genes
(S1 Table Candidate genes and selected SNPs). Candidate SNPs were selected based on previ-
ous association with childhood asthma, and a minor allele frequency of at least 10% (www.
hapmap.org phase I, II & III or literature). In total, 27 of the SNPs were analysed by using a
mass-spectroscopy based, high-throughput Mass ARRAY iPLEX platform (Sequenom Inc.,
Hamburg, Germany) using three multiplex genotyping reactions. Sequences were evaluated by
ProxSNP and PreXTEND software (http:www.realsnp.com). Sequenom Assay Designer 3.1
software was used to create the different multiplexes. Genotyping was performed according to
the iPLEX method. Primer and probe information is provided in S2_Table.docx Primer se-
quences used for genotyping by Sequenom. Three of the selected SNPs could not be fitted into
the multiplex reactions (rs1805010, rs2243250, rs3741240), and therefore these SNPs were de-
termined by Taqman genotyping assays ID C_2769554_10, ID C_16176216_10 and ID
C_25473445_10 (Applied Biosystems, California, USA).
The KOALA Birth Cohort Study
Study population of the KOALA Birth Cohort Study. The KOALA study (the Child,
Parent and Health: Lifestyle and, Genetic Constitution study) is a prospective study in the
Netherlands with the goal of investigating early life risk factors for atopy and asthma.[13] Preg-
nant healthy women (2,343 women with conventional lifestyle and 491 women with alternative
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lifestyles) were enrolled at 34 weeks of gestation. Parents were asked to take a buccal swab sam-
ple from the child for DNA isolation. From the group of 1,656 children with DNA available,
43 were excluded for congenital conditions like Down’s syndrome and cystic fibrosis or missing
baseline data. In the remaining group, follow-up on respiratory complaints until age four years
was complete in 1,364 (85%) children. For the main analysis, only the children with recurrent
wheeze (4 episodes in one questionnaire or at least one episode in multiple questionnaires
until four years of age according to the ISAAC questionnaire) and a definitive classification
(asthma or transient wheeze) at six to seven years of age were included (n = 248).
Asthma diagnosis in the KOALA Birth Cohort Study. Asthma at age six to seven years
was defined as ever physician diagnosed asthma with clinical symptoms and/or the use of asth-
ma medication in the last 12 months, adapted from the ISAAC questionnaire.[10] Clinical
symptoms were defined as having had at least 1 episode of wheeze or dyspnoea in the last
12 months. The use of asthma medication was defined as regular use (everyday use during at
least 2 months or use associated with physical activity) of short-acting β2-agonists or the use of
inhaled corticosteroids, and medication use according to the Dutch guidelines of treatment of
bronchial asthma in children.[14]
DNA isolation and genotyping in the KOALA Birth Cohort Study. Parents were asked
to collect buccal swabs from their children. Genomic DNA was extracted from these swabs by
standard methods.[15] DNA was amplified by using REPLI-g UltraFast technology (Qiagen,
Hilden, Germany). Participants were genotyped for five SNPs in three genes that had demon-
strated an association with an asthma classification at age six in the ADEM study. Genotyping
was performed by Competitive Allele-Specific PCR by using KASPar genotyping chemistry,
under contract by LGC Genomics (LGC, Teddington, UK) with extensive quality control as
described previously.[16]
Ethics statement
The ADEM study protocol was approved by the Dutch Central Committee on Research Involv-
ing Human Subjects. The KOALA study was approved by the Ethical Committee of the Uni-
versity Hospital of Maastricht. All parents signed informed consent.
Statistical analysis
IBM SPSS version 20 was used for data analysis (SPSS inc., Chicago IL, USA). Differences in
baseline characteristics were evaluated by chi-square test for categorical variables and indepen-
dent t-tests for continuous parametric variables. The Hardy-Weinberg equilibrium was calcu-
lated for each SNP based on a chi-square test and defined deviant in case of a p0.05.
Furthermore, Linkage disequilibrium (LD) was calculated with Haploview to demonstrate the
relationship between SNPs.[17] No attempt was made to analyse the association of haplotypes.
Logistic regression with outcome transient wheezer or true asthmatic was performed for each
individual SNP. Models were adjusted for sex and exposure to parental smoking and furry pets
assessed at time of asthma diagnosis on basis of previous literature and remained in the model
irrespective of their statistical significance.[18,19] Both, adjusted and unadjusted results were
displayed in the tables. SNPs were tested according to a co-dominant model as this model has
been shown to be the most powerful model over the additive, recessive and dominant model to
detect associations when the inheritance model is not known.[20] In case the genotype of the
two variant alleles was present in<10% of the population of the ADEM study, a dominant
model was applied. In case a significant association was observed, all models (co-dominant,
dominant and recessive) were applied if the genotype of the two variant alleles was present in
10%.
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SNPs that demonstrated an association of p<0.10 with the asthma classification in the
ADEM study were replicated in the KOALA study and were considered statistically significant
when p<0.05. Finally, for SNPs that demonstrated successful replication, we evaluated their as-
sociation with early wheeze (in order to distinguish it from progression from wheeze to asthma
at age four. This was done by logistic regression (adjusted for sex and exposure to parental
smoking and furry pets) in the children from the KOALA study with complete follow-up until
age four years, with recurrent wheeze as the outcome.
Power calculation
Due to the specific selection of wheezing children, we anticipated to find large ORs. A group of
146 transient wheezers and 73 asthmatics is sufficient to detect associations with an OR of 2.2
in allele frequency in a dominant model, when assuming the presence of one or more variant
alleles of at least 20% in transient wheezers with a power of 0.80 and an alpha of 0.10.
Results
The ADEM study
Population characteristics. In four children a diagnosis at six years of age could not be as-
sessed due to personal constraints of the parents such as lack of time and interest, leaving 198
children in the current analysis. At the age of six years, 122 children were classified as ‘transient
wheezer’ and 76 as ‘true asthmatic’. Characteristics are displayed in Table 1. At the age of six,
atopy was higher in the asthmatic group compared to the transient wheeze group.
Association of genetic variants with childhood asthma. DNA extraction was successful for
all children. All SNPs had a high call rate (92–100%, S1 Table Candidate genes and selected
SNPs). No deviation from Hardy-Weinberg equilibrium was observed (p0.05) with the excep-
tion of IL1RL1 rs1861245 and TLR9 rs5743836 (S1 Table Candidate genes and selected SNPs).
Three LD blocks were identified (block 1: R2 = 0.65 for ADAM33 rs528557 and rs511898; block 2:
R2 = 0.56 for IL4R rs1805011 and rs1805015, R2 = 0.45 for IL4R rs1805011 and rs1801275, R2 =
0.69 for IL4R rs1805015 and rs1801275; block 3: R2 = 0.13 for TLR9 rs187084 and rs5743836).
The TT-genotype of ADAM33 rs511898 (p = 0.03), the CG/GG-genotype of ADAM33
rs528557 (p = 0.08) and the TT-genotype of ORMDL3/GSDMB rs7216389 (p = 0.08) were neg-
atively associated with childhood asthma. The CT/TT-genotype of IL4 rs2070874 (p = 0.07)
and the CT/TT-genotype of rs2243250 (p = 0.06) were positively associated with childhood
asthma (Table 2 and Fig. 1). For ADAM33 rs511898 and ORMDL3/GSDMB rs7216389 results
of the recessive and dominant model are presented in S3 Table results of the additional model
analysis of significant genetic variants in the ADEM study. For ADAM33 rs528557, IL4
rs2070874 and IL4 rs2243250 no alternative models were calculated as the genotype of the two
variant alleles was present in<10% of the population. None of the other tested genetic variants
demonstrated an association with childhood asthma (S4 Table results for analysis of genetic
variants in the ADEM study).
Odds ratios with 95% confidence intervals (horizontal bars) from logistic regression analysis
for both the ADEM study and the KOALA study adjusted for sex, exposure to parental smok-
ing and furry pets for those SNPs that demonstrated a significant association with asthma
based on a p<0.10 in the ADEM study. Abbreviations: ref; reference category.
The KOALA Birth Cohort Study
Population characteristics. At four years of age, for 1,364 children DNA was available
and wheeze classification known (recurrent wheeze versus no recurrent wheeze). Children
ADAM33 Associates with Progression of Wheeze into Childhood Asthma
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could only be defined as a child without recurrent wheeze in case all questionnaires until the
age of four years were available (n = 1,079). Of the children with recurrent wheeze (n = 285), a
definitive classification (asthma or transient wheeze) at the age of six to seven years could not
be assessed in 37 children due to missing data. Consequently, a definitive classification (asthma
or transient wheeze) was available in 248 children with recurrent wheeze (191 children with
transient wheeze and 57 children with asthma). Eczema was significantly more frequent and
exposure to furry pets was significantly less frequent in asthmatics compared to transient whee-
zers at six years of age (Table 1).
Table 1. Characteristics of the study populations.
ADEM study KOALA study
Transient wheeze N = 122 True asthma N = 76 Transient wheeze N = 191 True asthma N = 57
Age (years), mean (SD) 6.0 (0.1) 6.0 (0.1) 6.5 (0.6) 6.5 (0.5)
Sex: male / female, in n 63/59 46/30 108/83 37/20
White European descent, %† 95 92 97 96
Atopy, %‡,§ 31 47* 79 71
Eczema, % 38 47 39 71*
Exposure to furry pets, % 53 51 49 26*
Exposure to parental smoking, % 36 25 7 2
Parental asthma§, % 28 43 28 36
Abbreviations: SD: Standard Deviation; n: number of children; ADEM study: Asthma DEtection and Monitoring study; KOALA study: Kind, Ouders en
gezondheid: Aandacht voor Leefstijl en Aanleg study.
† White European descent was deﬁned as at least 3 grandparents from white European (almost all Dutch ancestry) descent.
‡ Atopy was deﬁned as speciﬁc IgE concentration against a mixture of inhalant and food allergens of  0.35 kU/l on the Phadiatop Infant test (Pharmacia,
Uppsala, Sweden).
* p<0.05.
§based on a limited number of individuals (84 recurrent wheezers, 52 transient wheezers and 27 asthmatics) in the KOALA study.
doi:10.1371/journal.pone.0119349.t001
Table 2. Genetic variants associated with asthma in the ADEM study.
Gene SNP allele A/TW (n) OR 95%CI p ORa 95%CIa pa
ADAM33 rs511898 CC 32/40 1.00 Reference 1.00 Reference
CT 38/60 0.81 0.43–1.49 0.49 0.78 0.42–1.47 0.44
TT 5/21 0.30 0.10–0.88 0.03 0.30 0.10–0.90 0.03
rs528557 CC 41/49 1.00 Reference 1.00 Reference
CG/GG 35/73 0.58 0.33–1.04 0.07 0.59 0.33–1.06 0.08
IL4 rs2070874 CC 49/96 1.00 Reference 1.00 Reference
CT/TT 26/25 2.02 1.05–3.86 0.03 1.86 0.96–3.60 0.07
rs2243250 CC 46/93 1.00 Reference 1.00 Reference
CT/TT 27/25 2.16 1.13–4.13 0.02 1.92 0.98–3.74 0.06
ORMDL3/GSDMB rs7216389 CC 6/20 1.00 Reference 1.00 Reference
CT 41/67 0.75 0.40–1.41 0.37 0.80 0.42–1.51 0.49
TT 29/35 0.36 0.13–1.02 0.06 0.39 0.14–1.13 0.08
aAdjusted for sex, exposure to parental smoking and furry pets.
Abbreviations: 95%CI: 95% Conﬁdence Interval; A: Asthma; n: number of children; OR: Odds Ratio; p: p-value; TW: Transient Wheeze.
doi:10.1371/journal.pone.0119349.t002
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Replication of associated genetic variants with childhood asthma. All SNPs had a high
call-rate (93–96%). No deviation from Hardy-Weinberg equilibrium was observed (p0.05).
Furthermore, LD was calculated (R2 = 0.63 for ADAM33 rs511898 and rs528557, R2 = 0.00 for
IL4 rs2070874 and rs2243250). In the children with recurrent wheeze the CG/GG-genotype of
ADAM33 rs528557 was significantly negatively associated with subsequent childhood asthma
when compared to the asthma group (OR (95%CI): 0.50 (0.26–0.97) p = 0.04, Fig. 1 and
Table 3). No alternative models were displayed as the genotype of the two variant alleles was
present in<10% of the population. When the analysis was restricted to participants with a con-
ventional lifestyle (n = 199), the association did not change (OR (95%CI): 0.46 (0.22–0.94), p =
0.03). ADAM33 rs511898, ORMDL3/GSDMB rs7216389, IL4 rs2070874 and IL4 rs2243250
polymorphisms were not associated with childhood asthma in the KOALA study at a 0.05
significance level.
Association between ADAM33 rs528557 and recurrent wheeze at age four. For the repli-
cated gene variant ADAM33 rs528557 we assessed the role in the presence of recurrent wheeze
in the 1,364 children with complete follow-up until age four years, 285 children with recurrent
Fig 1. Genetic variants associated with progression from preschool wheeze into childhood asthma in the ADEM study (n = 198) with replication in
the KOALA Birth Cohort Study (n = 248)
doi:10.1371/journal.pone.0119349.g001
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wheeze and 1,079 without recurrent wheeze. The CG/GG-genotype of ADAM33 rs528557 was
not associated with recurrent wheeze at age four (OR (95%CI): 1.03 (0.77–1.39), p = 0.82).
Discussion
Multiple genetic variants in asthma candidate genes were assessed to determine their relation-
ship with the presence of asthma at six years of age in a group of 202 children with recurrent
wheeze at preschool age. We demonstrated association of ADAM33, IL4 and ORMDL3/
GSDMB gene polymorphisms with childhood asthma. In an independent birth cohort study
we were able to replicate the significant negative association of the CG/GG-genotype of
ADAM33 rs528557 with childhood asthma at age six. Since no association was found for this
SNP when assessing wheeze at age four, we demonstrated that ADAM33 is mainly involved in
the progression of wheeze into childhood asthma rather than being involved in the presence of
recurrent wheeze. The other associations could not be replicated.
ADAM33 was first reported as a susceptibility gene for asthma and bronchial hyper-respon-
siveness through genome wide linkage analysis identifying a candidate region on chromosome
20p.[21] ADAM33 consists of 22 exons which can generate a protein with eight different func-
tional domains.[22] The gene is highly polymorphic, containing more than 70 SNPs with ex-
tensive LD. [23–25] Some of the disease-related SNPs encode amino acid changes.[26] Other
SNPs are located in the non-coding regions and may affect proliferation of (myo)fibroblasts
and smooth muscle and/or inflammation of the airways by alternative splicing and splicing ef-
ficiency of messenger RNA turnover or their association is based on linkage with other SNPs.
[21,23,26–30] In previous studies, polymorphisms in ADAM33 have been related to childhood
asthma [21,24,31] and impaired lung function in early life in one study.[32] In the present
study we found a negative association of the ADAM33 rs528557 and rs511898 polymorphism
with progression of wheeze into childhood asthma. The replication of the negative association
of the CG/GG-genotype of rs528557 with childhood asthma in an independent birth cohort
study (KOALA study) confirms the relationship of this gene with childhood asthma in (Cauca-
sian) children with recurrent wheeze. Contrary to our findings, the study by van Eerdewegh
et al. revealed a positive association of this SNP with asthma in a genome wide scan in 460
Table 3. Replication of associated genetic variants in the KOALA Birth Cohort Study.
Gene SNP allele A/TW (n) OR 95%CI p ORa 95%CIa pa
ADAM33 rs511898 CC 26/76 1.00 Reference 1.00 Reference
CT 21/91 0.68 0.35–1.29 0.24 0.60 0.30–1.19 0.14
TT 9/12 2.19 0.83–5.80 0.11 2.28 0.82–6.34 0.11
rs528557 CC 35/94 1.00 Reference 1.00 Reference
CG/GG 20/82 0.66 0.35–1.22 0.18 0.50 0.26–0.97 0.04
IL4 rs2070874 CC 41/124 1.00 Reference 1.00 Reference
CT/TT 14/57 0.74 0.38–1.47 0.39 0.74 0.37–1.50 0.41
rs2243250 CC 40/120 1.00 Reference 1.00 Reference
CT/TT 13/55 0.71 0.35–1.43 0.34 0.72 0.35–1.47 0.36
ORMDL3 /GSDMB rs7216389 CC 7/39 1.00 Reference 1.00 Reference
CT 33/89 2.07 0.84–5.07 0.11 2.00 0.78–5.10 0.15
TT 15/54 1.55 0.58–4.15 0.39 1.49 0.54–4.11 0.44
aAdjusted for sex, exposure to parental smoking and furry pets. Abbreviations: 95%CI: 95% Conﬁdence Interval; A: Asthma; n: number of children; OR:
Odds Ratio; p: p-value; TW: Transient Wheeze.
doi:10.1371/journal.pone.0119349.t003
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Caucasian asthma affected sib-pair families.[21] As the rs528557 polymorphism does not lead
to an amino acid change, this conflicting observation might be based on variability of LD be-
tween the studied populations. Another explanation might be the pre-selection we applied on
children with preschool wheeze resulting in a different stage of asthma development. This was
further emphasised by our demonstration that the ADAM33 rs528557 CG/GG-genotype was
not associated with recurrent wheeze at four years of age. Consequently, this SNP is associated
with the progression of wheeze into childhood asthma rather than with recurrent
preschool wheeze.
ORMDL3/GSDMB is mapped to a locus on chromosome 17q12–21, which was first identi-
fied in association with childhood asthma through genome-wide analysis.[33] Since then,
other studies have confirmed an association of ORMDL3/GSDMB with childhood asthma,
making it the strongest replicated gene for childhood asthma.[34–37] Its function is still un-
known, but it has been suggested that it might have a role in airway remodelling, the epithelial
barrier function, or eosinophil trafficking.[38–40] In the present study, the CC-genotype of
rs7216389 in ORMDL3/GSDMB was demonstrated to be borderline significantly associated
with childhood asthma. However, replication failed in the independent birth cohort study. In
contrast to our findings, previous studies identified the T-allele of rs7216389 in ORMDL3/
GSDMB as the childhood asthma risk allele.[34,35,37] Exposure to environmental factors such
as tobacco smoke and domestic furry pets, have been demonstrated to modify the relationship
between polymorphisms in ORMDL3/GSDMB and childhood asthma.[41,42] Remarkable was
the difference in prevalence of parental smoking between the ADEM and the KOALA study
even though the same definition for passive smoking was used. This is probably due to the dif-
ferent recruitment strategies of the studies. In our analysis correction for sex, exposure of pa-
rental smoking and furry pets did not influence our findings. However, we did not assess effect
modification in the current study. Furthermore, it might be that unknown environmental in-
fluences affect the relationship of ORMDL3/GSDMB with asthma, which may explain the dif-
ference between our findings and those of others. Moreover, the small sample size of our study
might have led to spurious findings due to limited power.
IL4maps to a cytokine cluster on chromosome 5q31-q33.[43–45] It is a pro-inflammatory
cytokine that is involved in a number of immunoregulatory pathways such as the induction of
IgE synthesis by B-cells and differentiation of T-helper-type-2 lymphocytes.[43–46] IL4 has
been linked to asthma phenotypes and atopy in several studies[43,44] including childhood
populations.[45,47] In accordance with these findings, we found associations of two SNPs in
IL4 with childhood asthma. This strengthens the suggestion, brought out by previous studies,
that children with CT/TT-genotypes for rs2070874 and rs2243250 run an increased risk of de-
veloping asthma. Unfortunately, we were unable to replicate these findings in the independent
birth cohort study, possibly due to low power.
As seen in the present study, many asthma candidate gene studies are confronted with fail-
ure of replication or even opposite findings in independent studies.[32] There are multiple
causes for failure of replication. Firstly, asthma is caused by different polymorphisms that do
not need to be universal, leading to genetic heterogeneity.[24,29,32,47,48] In addition, the gene
effects are small and they may be subject to ethnic diversity and variability in LD between pop-
ulations, which can lead to population specific results.[43,46] However, the populations of the
ADEM study and the KOALA study have, based on region, ethnicity, and genetic origin, simi-
lar population characteristics. Furthermore, methodological differences between the studies
can influence findings. For example, the definition of asthma used, varies between studies, re-
sulting in different phenotypes. As the asthma classification in the KOALA study differed from
the ADEM study, this might be the cause of replication failure in four of the five childhood
asthma associated genetic variants. In the ADEM study, the definition of asthma was based on
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symptoms, lung function features and asthma medication with a high rate of concordance be-
tween a doctor diagnosis of asthma and the diagnosis by means of a computer algorithm. In
the KOALA study the diagnosis of asthma was based on clinical symptoms and the use of asth-
ma medication which is a universal accepted definition in this type of studies. In addition, it is
generally known that environmental influences can affect or even change the direction of un-
derlying associations. Therefore, different environmental conditions between studied popula-
tions can be responsible for failure of replication.[29,32,48] In our analysis, we corrected for
passive smoking and exposure to furry pets. We cannot fully exclude an influence by other (un-
known) environmental factors. Moreover, we concentrated on candidate polymorphisms in-
stead of a complete assessment of all genetic variants due to power restrictions. Although no
complete coverage of the variation of each candidate gene was guaranteed as would be the case
for tagSNPs, the selected SNPs have previously been proven to be important in association
with childhood asthma. Consequently, testing these specific hypotheses, the a priori chance of
finding contributing SNPs is large. Thus, we choose not to correct for multiple testing these
specific hypotheses. Another reason to ignore multiple testing correction is replication in an in-
dependent study which reduces the chance of finding spurious associations. Finally, observed
associations can also be caused solely by LD.[29,30,45] Naturally, a significant finding based on
chance can also be a cause of replication failure.
In contrast to mentioned limitations, our study has several strengths. The design of the
ADEM study enabled us to follow a large group of children with recurrent wheeze at preschool
age until the asthma classification at six years of age. Furthermore, our definition of asthma
was based on a clinical assessment and a computer-algorithm with re-assessment of inconclu-
sive cases. This is expected to result in a highly accurate classification. Furthermore, replication
of found associations was assessed in the independent KOALA study. A limitation of our study
might be that we did not correct for multiple testing. However, the use of an independent birth
cohort for replication reduced the likelihood of finding associations based on chance.
Conclusions
In conclusion, we assessed 30 genetic variants in 16 asthma candidate genes in relationship to
childhood asthma in a cohort of 202 children with recurrent wheeze. Polymorphisms in
ADAM33 (rs511898 and rs528557) and ORMDL3/GSDMB (rs7216389) were negatively associ-
ated and polymorphisms in IL4 (rs2070874 and rs2243250) were positively associated with
childhood asthma. In an independent birth cohort we were able to confirm the negative associ-
ation of ADAM33 rs528557 CG/GG-genotype with progression of recurrent wheeze into child-
hood asthma rather than with the presence of wheeze.
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